Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 5Prostate Adenocarcinoma 1Metastatic Castration-resistant Prostate Cancer 1Metastatic Castrate Resistant Prostate Cancer (mCRPC) 1Lymphatic Metastasis 1Carcinoma, Renal Cell 1Anatomic Stage IV Breast Cancer AJCC v8 1

Interventions

luprolide acetate gel depot 2acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 2Radiotherapy 2Radiation 2Leuprolide 2Goserelin 2relugolix 1radium Ra 223 dichloride 1histrelin 1gallium 68 PSMA-11 1darolutamide 1bicalutamide 1Triptorelin Pamoate 1Surgical Procedures, Operative 1Specimen Handling 1Salicylic Acid 1Radiosurgery 1Radiation Dose Hypofractionation 1Magnetic Resonance Spectroscopy 1Flutamide 1Buserelin 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Prostate Adenocarcinoma × radium Ra 223 dichloride × 90 days × Clear all
NCT03361735 2026-04-09

Radium Ra 223 Dichloride, Hormone Therapy and Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Prostate Cancer

City of Hope Medical Center

Phase 2 Active not recruiting
25 enrolled 10 charts
Genitourinary

Prostate Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡